You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 162 No. 15, August 12, 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Asthma
 •Statistics and Research Methods
 •Allergy
 •Medical Ethics
 •Randomized Controlled Trial
 •Alert me on articles by topic

Unnecessary Use of Placebo Controls

The Case of Asthma Clinical Trials

Arch Intern Med. 2002;162:1673-1677.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE ETHICS of placebo-controlled clinical trials has generated considerable controversy in recent years. Critics, often citing the Declaration of Helsinki, have argued that use of placebo controls is unethical in trials of medications to treat conditions for which proven effective treatments exist. Defenders of placebo-controlled trials contend that the alternative of clinical trials that compare active treatments without placebo controls are often subject to serious methodological weaknesses. In the present article we develop a middle-ground position on the ethics of placebo-controlled trials, which is applied to recent clinical trials of treatments for asthma. Questions are raised about 3 recent placebo-controlled asthma trials on the grounds that the scientific questions that these trials were designed to answer did not require use of placebo. However, use of placebo controls in initial trials of investigational treatments is defended, provided that patient volunteers randomized to placebo are not exposed to serious risks of irreversible . . . [Full Text of this Article]

BACKGROUND


THE ETHICAL DEBATE

TYPOLOGY OF PLACEBO-CONTROLLED TRIALS

PLACEBO-CONTROLLED TRIALS IN ASTHMA
Trials of Combination Therapy

Comparison of 2 Dosing Regimens

Can Informed Consent Justify Placebo Controls?

Initial Trials of Investigational Agents


CONCLUSIONS


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ethical Assessment of Clinical Asthma Trials Including Children Subjects
Coffey et al.
Pediatrics 2004;113:87-94.
ABSTRACT | FULL TEXT  

Continued Need for Placebo in Many Cases, Even When There Is Effective Therapy
Miller and Shorr
Arch Intern Med 2003;163:373-373.
FULL TEXT  

Continued Need for Placebo in Many Cases, Even When There Is Effective Therapy
Temple and Meyer
Arch Intern Med 2003;163:371-371.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.